At a glance
ClinicalIndex Comparison RecordN/ACompleted· 763 enrolled
Drug / intervention
Etanerceptdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Long Term Adherence and Efficacy of Etanercept in SpA Iraqi Patients: 7 Year Data From Local Registry
In Brief
An observational study evaluating Etanercept for Spondyloarthrosis. Completed, enrolled 763 participants across 1 site.
Detailed Summary
This study is to evaluate local data in Iraqi patients with Spondyloarthropathies on Enbrel treatment with regards to efficacy and adherence using data from the Baghdad Teaching Hospital (Rheumatology Center)
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSpondyloarthrosis
CountriesIraq
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedAug 2020
Enrollment StartSep 2020
Primary CompletionOct 2020
TodayJul 2026
First PostedAug 11, 2020
Enrollment StartSep 1, 2020
Primary CompletionOct 1, 2020
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 5.9 years ago
Interventions
Etanerceptdrug
Patients with spondyloarthrosis as provided in real world practice